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Abstract
Background: Laminin a2 chain mutations cause congenital muscular dystrophy with dysmyelination neuropathy (MDC1A).
Previously, we demonstrated that laminin a1 chain ameliorates the disease in mice. Dystroglycan and integrins are major
laminin receptors. Unlike laminin a2 chain, a1 chain binds the receptors by separate domains; laminin globular (LG) domains
4 and LG1-3, respectively. Thus, the laminin a1 chain is an excellent tool to distinguish between the roles of dystroglycan
and integrins in the neuromuscular system.
Methodology/Principal Findings: Here, we provide insights into the functions of laminin a1LG domains and the division of
their roles in MDC1A pathogenesis and rescue. Overexpression of laminin a1 chain that lacks the dystroglycan binding LG4-
5 domains in a2 chain deficient mice resulted in prolonged lifespan and improved health. Importantly, diaphragm and heart
muscles were corrected, whereas limb muscles were dystrophic, indicating that different muscles have different
requirements for LG4-5 domains. Furthermore, the regenerative capacity of the skeletal muscle did not depend on laminin
a1LG4-5. However, this domain was crucial for preventing apoptosis in limb muscles, essential for myelination in peripheral
nerve and important for basement membrane assembly.
Conclusions/Significance: These results show that laminin a1LG domains and consequently their receptors have disparate
functions in the neuromuscular system. Understanding these interactions could contribute to design and optimization of
future medical treatment for MDC1A patients.
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Introduction
Congenital muscular dystrophy type 1A (MDC1A) is an
autosomal recessive disorder caused by mutations in the gene
encoding laminin (LM) a2 chain. The general clinical hallmarks of
MDC1A include neonatal onset of muscle weakness, hypotonia
often associated with joint contractures, inability to stand and
walk, elevated levels of creatine kinase, white matter abnormalities
and dysmyelination neuropathy. Histological changes of muscles
comprise fiber size variability, massive degeneration and extensive
connective tissue infiltration. Most patients die as teenagers since
there is no treatment for this devastating disease [1]. Several
mouse models for MDC1A exist (e.g. generated LMa2 chain
mutants dy
3K/dy
3Kand dy
W/dy
W and the spontaneous mutant
mouse strain dy/dy) and they adequately mirror the human
condition [2–4].
LMs are extracellular proteins formed by a, b and c chains.
Together with other extracellular matrix components LMs form
specialized extracellular matrices called basement membranes [5].
LM-211 (composed of a2, b1 and c1 chains) is the major LM
isoform expressed in muscle and peripheral nerve. Through
interaction with transmembrane receptors it regulates major
functions of the neuromuscular system and provides structural
support to muscle fibers [6]. In muscle, at least two distinct protein
complexes are known to be the key receptors for LMa2 chain;
dystroglycan and integrin a7b1. Their importance is underscored
by the fact that absence of integrin a7 chain, as well as
hypoglycosylation of a-dystroglycan cause various forms of
congenital muscular dystrophy [7,8]. Furthermore, different
studies involving manipulation of the dystroglycan gene in mice
revealed an important role for dystroglycan in skeletal muscle
[9–11]. Several studies indicated that the function of integrin a7
subunit and dystroglycan, being a part of the dystrophin-
glycoprotein complex, could overlap [12–14]. However, recent
studies show that whereas both dystroglycan and integrin a7 chain
contribute to force-production of muscles, only dystroglycan
contributes to the preservation of sarcolemmal integrity [15].
LMa2 chain receptors present in peripheral nerve include
dystroglycan, integrins a6b1, a7b1 and possibly integrin a6b4
[16,17]. Dystroglycan, b1 and b4 integrin subunits have been
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morphology of peripheral nerves, as revealed by conditional
disruption of their genes in Schwann cells [18–20]. Thus, LM-211
is a central player linking these receptors and their functions in the
neuromuscular system.
LMa1 chain also binds to dystroglycan, integrin a6b1 and
integrin a7b1 (and perhaps integrin a6b4) [17,21–24]. Yet, it is
not expressed in the neuromuscular system [25]. We have
previously explored the possibilities of paralogous gene therapy
for MDC1A and demonstrated that LMa1 chain is an excellent
substitute for LMa2 chain in murine muscle, peripheral nerve and
testis [25–28]. Additionally, LMa2 chain deficiency leads to
perturbed expression of integrin a7 subunit, and reduced
expression of the core protein of a-dystroglycan (but not a-
dystroglycan glycosylation), at the sarcolemma [29–31]. Notably,
LMa1 chain overexpression restores integrin a7 chain expression,
indicating that this receptor could be crucial for improvement of
muscle function in dystrophic animals [32].
The LMa1 and a2 chains bind dystroglycan and integrins by
distinct domains. The a1 chain binds dystroglycan via its C-
terminal LG4 domain and integrin binding occurs via a1LG1-3
[33,34]. This is different from LMa2 chain binding where there is
considerable overlap in binding to dystroglycan and integrins.
Both a2LG4-5 and a2LG1-3 bind dystroglycan, whereas only
a2LG1-3 binds integrins [23,35]. The LMa1 chain can thus be
used more efficiently to distinguish between the roles of LM
binding to dystroglycan and integrins in the neuromuscular
system. Since LMa1 chain functions almost equally well as a2
chain in the neuromuscular system, we used this subunit in order
to dissect the roles of the aLG domains and their receptors in
MDC1A pathogenesis and rescue. Hence, we produced and
characterized animals completely deficient in LMa2 chain, but
instead overexpressing a truncated form of LMa1 chain (dy
3K/dE3
mice) that lacks the dystroglycan binding site (LG4-5 domains at
the C-terminus, also known as the E3 fragment), but retains the
integrin binding site (LG1-3, see Fig. 1A) [33,34].
Materials and Methods
Ethics statement
All mouse experimentation was approved by the local (Lund
district) ethics committee (permit number M62-09). All mice were
maintained in animal facilities according to animal care guidelines.
Transgenic construct
Approximately 1 kb of the C-terminal part was removed from
mouse full-length LMa1 chain cDNA to generate truncated
cDNA (dE3LMa1 ) .A ni nf r a m ed e l e t i o nb e t w e e nn u c l e o t i d e s
8248–9289 (corresponding to LG4-5 domains) was accom-
plished by DraIII-SmaI restriction cutting and fusion of an
XhoI site with a BglII site. This DNA was cloned into the
pCAGGS vector [25], containing a CMV enhancer and a b-
actin promoter.
Transgenic animals
Transgenic mice were generated by microinjections of
transgene DNA into the pronucleus of fertilized single-cell
C57BL/CBA embryos (Lund Transgenic Core Facility, Lund
University, Sweden). Mice carrying dE3LMa1c h a i nD N Aw e r e
identified by PCR as described previously [25]. Positive
founders overexpressing truncated LMa1 chain in the neuro-
muscular system (lines No. 3 and 4) were further bred with
dy
3K/+ mice [2], followed by sib breeding to generate LMa2
chain deficient animals that express dE3LMa1c h a i n( d y
3K/dE3
mice). Dy
3K/dy
3K mice overexpressing full length LMa1c h a i n
(dy
3KLMa1 mice) were previously described [25–28]. Dy/dy
mice used for heart studies were obtained from Jackson
Laboratory.
Exploratory locomotion and body and muscle weight
analyses
Exploratory locomotion was examined in an open field test. A
mouse was placed into a new cage and allowed to explore the cage
for 5 min. The time that the mouse spent moving around was
measured. For all experiments, 10-week-old dy
3K/dE3 animals
(n=16) were compared with 10-week-old control mice (wild-type
or dy
3K/+) (n=8) and 5-week-old dy
3K/dy
3K mice (n=6). For
weight analysis dy
3K/dE3, control mice and dy
3K/dy
3K animals
were sex- and age-matched (5-week-old) (n=14, n=3, n=11,
respectively, for females; n=8, n=4, n=8, respectively, for
males). Quadriceps and tibialis anterior muscles from 2-month-old
wild-type (n=3), dy
3K/dE3 (n=3) and 4-week-old dy
3K/dy
3K
mice (n=4) were used to estimate the ratio of wet muscle weight to
body weight. Muscles from both legs were weighed and average
muscle mass was calculated. Unpaired t-test was used for statistical
analysis.
Creatine kinase activity
Blood was collected from the tail vein of 2-month-old control
mice (wild-type or dy
3K/+) (n=10), dy
3K/dE3 (n=10) and 4-week-
old dy
3K/dy
3K mice (n=3) into EDTA-tubes and spun down two
times for 5 minutes at 3500 rpm. CK_P_S_cobas method was
used by Clinical Chemistry Laboratory at Ska ˚ne University
Figure 1. Generation of dE3LMa1 transgenic animals. (A) Scheme presenting LM-111 structure. Full-length LMa1 chain with LG1-5 domains
and truncated LMa1 chain (dE3LMa1) with LG1-3 domains are marked together with their transmembrane receptors. (B) Schematic presentation of
transgenic construct with denoted 1 kb deletion (LG4-5). Restriction sites used to engineer the construct are shown.
doi:10.1371/journal.pone.0011549.g001
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was used for statistical analyses.
Histology and immunofluorescence microscopy
Skeletal muscle, heart, peripheral nerve and spinal roots
cryosections (7 mm) from control (wild-type or dy
3K/+), dy
3K/dy
3K,
dy/dy, dy
3K/dE3 and dy
3KLMa1 mice were either stained with
hematoxylin and eosin or subjected to immunofluorescence
analysis using following antibodies: rat monoclonal mAb200
against LMa1LG4 domain [25], rabbit polyclonal 1057+ against
LMa1 LN/LEa domain (N-terminus) (kindly provided by Dr. T.
Sasaki) [36], rabbit polyclonal 1100+ against LMa4, (kindly
provided by Dr. T. Sasaki), rabbit polyclonal 1113+ against
LMa5 (kindly provided by Dr. T. Sasaki), rat monoclonal
MTn15 against tenascin-C [25], rabbit polyclonal U31 against
integrin a7B subunit (kindly provided by Dr. U. Mayer) [37],
mouse monoclonal IIH6 against a-dystroglycan (Upstate Bio-
technology), mouse monoclonal F1.652 against embryonic
myosin heavy chain (Developmental Studies Hybridoma Bank,
Iowa), rabbit polyclonal anti-collagen, type IV (Chemicon),
mouse monoclonal 46 against caspase-3 (BD Transduction
Laboratories). Mouse on mouse kit (Vector) was used for staining
with embryonic myosin heavy chain according to manufacturer
instructions. Tissues were fixed with 4% PFA at room
temperature (for laminin, tenascin-C, embryonic myosin heavy
chain, collagen-IV and caspase-3 stainings), or with acetone at
220uC (for integrin a7B) or with 8% formaldehyde, followed by
methanol at 220uC (for a-dystroglycan). Sections were analyzed
using a Zeiss Axioplan fluorescence microscope. Images were
captured using an ORCA 1394 ER digital camera with Openlab
3 software. Images were prepared for publication using Adobe
Photoshop software.
Immunoblotting
For LM detection proteins were isolated from 100 mg of dy
3K/
dE3 and dy
3KLMa1 muscles (3 mice from each group) by brief
sonication in 1 mmol/L EDTA in TBS with 1:25 dilution of
protease inhibitors (Complete EDTA-free, Roche Diagnostics).
For integrin detection proteins were extracted from 100 mg
skeletal homogenized muscle powder of 3 wild-type and dy
3K/dE3
mice in 1% Triton X-100, 50 mM Tris-HCl, pH 7,4; 1 mM
CaCl2, 1 mM MgCl2 and 1:25 dilution of Protease Cocktail
(Complete EDTA-free, Roche Diagnostics). Samples were incu-
bated for 1 hour and spun down at 4uC. The supernatants were
collected and the protein concentration was determined using
BCA assay (Pierce). Dystroglycan was isolated using agarose
bound wheat germ agglutinin (Vector) and N-acetyl-D-glucos-
amine (Sigma) as described before [32]. Lysates containing LM,
integrin and dystroglycan were separated on 5% or 8%
polyacrylamide-SDS gels under reducing or non-reducing condi-
tions. EHS LM (Invitrogen) was used as a control for LM blotting.
Proteins were transferred to nitrocellulose membranes (Amer-
sham). Membranes were blocked for 1 hour in 5% non-fat dry
milk in 1xTBS with 0.02% Tween-20 and incubated overnight at
4uC with a rabbit polyclonal antibody detecting LMa1LG3
domain (kindly provided by Dr. T. Sasaki); rabbit polyclonal
antibody against integrin a7B (kindly provided by Dr. U. Mayer);
rabbit polyclonal antibody against b-dystroglycan [25] and mouse
monoclonal antibody IIH6 against a-dystroglycan. Detection was
performed with ECL kit (Amersham). Expression of LMa1 chain,
integrin a7B subunit, a- and b-dystroglycan was normalized to a-
actinin expression (detected with mouse monoclonal antibody EA-
53, Sigma). Band intensity was measured using ImageJ software.
Unpaired t-test was used for statistical analyses.
Quantification of fiber size distribution, central
nucleation and fiber number
Diaphragm and limb muscles from at least 3 animals from each
group (4–6-week-old wild-type, dy
3K/dy
3K and dy
3K/dE3 mice) were
analyzed. Minimal Feret’s diameter was measured [38] for at least
2600 fibers for each group. The same number of fibers was used
for quantification of fibers with centrally located nuclei. An
additional group of 4–6-month-old dy
3K/dE3 animals was included
for quantification of diaphragm fibers. Fibers from quadriceps
muscle from 4–6-week-old wild-type (n=3), dy
3K/dy
3K (n=3) and
dy
3K/dE3 mice (n=3) were counted within a square of 64610
6
pixels
2. Unpaired t-test was used for statistical analysis.
Treadmill exercise and Evans blue dye injection
Dy
3K/dE3 mice (n=4) were exercised for 30 min on a treadmill
Exer 6M (Columbus Instruments) at a downhill angle of 15u.
During the first 2 min the speed was gradually increased from
7 m/min up to 14–16 m/min. Within 30 min after completed
exercise the mice were injected i.p. with Evans blue dye (EBD)
(Sigma Aldrich) dissolved in sterile saline (concentration: 0.5 mg
EBD/0.05 ml saline; amount: 50 ml per 10 g body weight). After
approximately 24 h, muscles were collected and quickly frozen in
liquid nitrogen. Unexercised mice were injected with EBD and
used as controls. Muscle cryosections (8 mm) were fixed in ice-cold
acetone at 220uC for 10 min, washed and mounted with
FluorSave (Calbiochem). By fluorescence microscopy analysis,
EBD uptake into muscle fibers was visualized by red emission.
Cardiotoxin injections
Tibialis anterior muscles from 6 control (wild-type or dy
3K/+),6
dy
3K/dy
3K and 6 dy
3K/dE3 mice were injected with cardiotoxin
(10 mmol/L in saline). Control and dy
3K/dE3 mice were 2–3-
month-old. Dy
3K/dy
3K mice were 3-week-old. Three mice from
each group were sacrificed 4 days after injection and the other 3
after 11 days. Both injected and contralateral uninjected tibialis
anterior muscles were collected and analyzed.
Electron microscopy and toluidine blue staining
Quadriceps femoris muscles, heart, diaphragm, sciatic nerves
and spinal roots from wild-type, dy
3K/dy
3K and dy
3K/dE3 mice were
fixed for 2 hours with 1.5% glutaraldehyde/1.5% paraformalde-
hyde, rinsed in So ¨rensen’s phosphate buffer, post fixed in 1%
OsO4 and then embedded in Epon. Ultra thin sections were
stained with uranyl acetate and lead citrate. Specimens were
examined by transmission electron microscopy (Philips CM 10).
Three to 4 animals from each group were analyzed.
Results
Generation of dy
3K/dy
3K mice overexpressing dE3LMa1
chain
We have generated mice overexpressing LMa1 chain devoid of
LG4-5 domains (comprising the E3 fragment) under the control of
a CMV enhancer and b-actin promoter (Fig. 1A and B) (dE3
mice), Mice overexpressing dE3LMa1 in skeletal muscle, periph-
eral nerve and heart were maintained (transgenic lines No. 3 and
4) (Figure S1, see also Fig. 2). The expression of truncated LMa1
chain was detected using antibodies against the N-terminal
domains of LMa1 chain and the LG4 domain, respectively.
Immunofluorescence staining with the antibody directed against
N-terminal domains of LMa1 chain demonstrated patchy
expression of truncated LMa1 chain in basement membranes of
skeletal and cardiac muscle, and in endoneurium and perineurium
Laminin receptors in MDC1A
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detected with the antibody directed towards LG4 domain,
indicating the overexpression of truncated LMa1 chain. Staining
with both antibodies was detected in LMa1TG mice overexpress-
ing full-length LMa1 chain (Figure S1) (described in 25) and it
indicated a higher level and more homogeneous expression of
LMa1 chain in these animals. Notably, overexpression of
truncated LMa1 chain in mice revealed no discernible patholog-
ical phenotypes.
Next, dE3 mice from line 3 and 4 were further mated with mice
carrying the mutation in Lama2 gene (dy
3K/+), to create mice that
are devoid of LMa2 chain but instead overexpress dE3LMa1
chain (dy
3K/dE3 mice).
Expression of truncated LMa1 chain is upregulated upon
LMa2 chain deficiency
We analyzed the expression of dE3LMa1c h a i ni ndy
3K/dE3
mice in a similar manner as in dE3 mice (only the staining with
the antibody against N-terminal domains is shown). Interestingly,
upon LMa2 chain deficiency the truncated LMa1 chain was
upregulated in all examined tissues (skeletal muscle, diaphragm,
heart, peripheral nerve) compared to dE3 mice (Fig. 2A). Also,
the expression levels seemed to reach those detected in dy
3KLMa1
mice overexpressing full-length LMa1 chain. We also noted
intracellular staining of truncated LMa1 chain in skeletal muscle
(Fig. 2A). Western blot analyses with an antibody against
LMa1LG3 domain revealed even higher expression (approxi-
mately 2.5-fold) of dE3LMa1 chain in dy
3K/dE3 muscles
compared to full-length LMa1 chain in dy
3KLMa1 muscles
(Fig. 2B). Therefore, we can rule out the possibility that the
observed phenotype of dy
3K/dE3 mice described below is due to
insufficient expression of truncated LMa1 chain. Also, it is clear
that the regulatory mechanisms involved in LMa1 chain
transgene expression are complex. We also assessed the
expression of LMa4a n da5 chains. We and others have
previously shown that expression of these two LM chains is
upregulated in LMa2 chain deficient basement membranes
[25,39] (see also Figure S2). In dy
3K/dE3 mice, the muscle
basement membrane expression of LMa4a n da5 chains was very
similar to that of dy
3K/dy
3K mice (Figure S2). Hence, we suggest
that the compensatory increase of LMa4 and LMa5c h a i n sh a s
no beneficial effects in dy
3K/dE3 muscles (which are analyzed in
detail in the next paragraphs).
Expression of integrin a7B and dystroglycan in dy
3K/dE3
tissues
We next evaluated the expression of integrin a7B and
dystroglycan in dy
3K/dE3 muscles. Expression of integrin a7B is
reduced at the sarcolemma of dy
3K/dy
3K limb and heart muscle but
to a lesser extent in dy
3K/dy
3K diaphragm (Fig. 3A). Notably, the
expression of integrin a7B subunit was restored in dy
3K/dE3 limb,
diaphragm and heart muscle (Fig. 3A). Similarly, also full-length
LMa1 chain reconstituted integrin a7B chain at LMa2 chain
deficient sarcolemma [32]. We further detected an approximately
4.5-fold upregulation of integrin a7B in dy
3K/dE3 skeletal muscle
by immunoblotting experiments (Fig. 3B).
LMa2 chain deficiency does not significantly alter a-dystrogly-
can glycosylation and b-dystroglycan expression at the sarcolem-
ma [32], probably because other ligands (e.g. perlecan) are still
present. By immunofluorescence analyses, expression of a-
dystroglycan also appeared normal in dy
3K/dE3 limb, diaphragm
and heart muscle and in sciatic nerve (Fig. 4A). In addition, we
quantified expression of a- and b-dystroglycan and they remained
the same in dy
3K/dE3 vs. control skeletal muscle (Fig. 4B).
All in all, these results suggest that integrin a7B is increased,
whereas dystroglycans appear normally expressed in dy
3K/dE3
muscles.
Dy
3K/dy
3K mice with dE3LMa1 transgene have improved
overall health
Dy
3K/dy
3K mice completely deficient in LMa2 chain were
previously described [2]. Briefly, these animals suffer from severe
muscle wasting, growth retardation, peripheral neuropathy and
die approximately 3–5 weeks after birth. As shown in Fig. 5, the
overall health of dy
3K/dE3 mice was improved compared to dy
3K/
dy
3K mice. First, dy
3K/dE3 mice live longer. As demonstrated by
the survival curve, approximately 75% of dy
3K/dE3 animals
survive up to 3 months (Fig. 5B). Further estimation of dy
3K/dE3
survival encountered obstacles. Due to hindleg paralysis, several of
them were sacrificed according to the guidelines of the ethical
permit. Nevertheless, many dy
3K/dE3 mice survive much longer
than 3 months. Our oldest animals died one year after birth.
Second, dy
3K/dE3 animals are bigger than dy
3K/dy
3K mice. At 2
weeks of age, dy
3K/dy
3K mice can be identified due to their growth
retardation whereas dy
3K/dE3 mice appeared outwardly normal
(data not shown). Furthermore, the majority of dy
3K/dE3 animals at
5 weeks of age can not be distinguished from normal littermates
(Fig. 5A). Weight gain for female and male dy
3K/dy
3K mice was
greatly delayed in 5-week-old mice whereas the weight gain for
female and male dy
3K/dE3 mice was significantly increased
compared to dy
3K/dy
3K mice (Fig. 5C and data not shown).
However, dy
3K/dE3 mice weigh significantly less than normal
littermates (Fig. 5C and data not shown). Beginning from 5 weeks of
age, the difference in overall phenotype between most of dy
3K/dE3
and wild-type mice became more evident. Many dy
3K/dE3 animals
are visibly smaller than control littermates (Fig. 5A, middle panel).
However, some of the older dy
3K/dE3 animals look outwardly
normal and are almost indistinguishable from their littermates
(Fig.5A,leftpanel).Also,theratioofquadricepsandtibialisanterior
wet weight per body weight was similar in control and dy
3K/dE3
mice, whereas the ratio was significantly reduced in dy
3K/dy
3K mice
(Fig. 5D and data not shown). Hence, muscle mass was maintained
in proportion to the body size in dy
3K/dE3 mice. Nevertheless, most
of dy
3K/dE3 mice display severe peripheral nerve abnormalities, as
demonstrated by temporary hindleg paralysis (either one or
occasionally two limbs) (Fig. 5A, arrow). When lifted by the tail,
they retract their hindlimbs toward the body. Still, dy
3K/dE3 mice
perform much better in the locomotion activity test compared to
dy
3K/dy
3Kanimals(Fig.5E),indicatingthat musclefunctionis largely
Figure 2. Comparison of expression levels of LMa1 chain between dE3 transgenic mice, dy
3K/dE3 and dy
3KLMa1 mice. (A) Truncated
LMa1 chain is upregulated in skeletal muscle (SM), diaphragm (Dia), peripheral nerve (SN) and heart (He) in dy
3K/dE3 mice compared to dE3 mice
expressing LMa2 chain. It reaches the levels of full-length LMa1 chain expression in dy
3KLMa1 mice. Three animals from each group were analyzed.
Bars, 50 mm. (B) Immunoblotting of tissue extracts from wild-type, dy
3K/dE3 and dy
3KLMa1 skeletal muscle and EHS extract with a rabbit polyclonal
antibody against LMa1LG3 domain. Quantification of signals revealed that there is approximately 2.5-fold more of truncated LMa1 chain in dy
3K/dE3
muscles compared to full-length LMa1 chain in dy
3KLMa1 muscles (p=0.0194). Results are shown as means 6 SEM. The shift in molecular weight of
truncated (350 kDa) vs. full-length (400 kDa) LMa1 chain became apparent after running the samples for a longer time (data not shown).
doi:10.1371/journal.pone.0011549.g002
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3K/dE3 mice move significantly less than control
mice and this is supposedly due to the temporary paralysis (Fig. 5E).
Finally, we noted that serum kinase activity was significantly
elevated in dy
3K/dE3 mice (Fig. 5F), indicating that muscles may be
dystrophic, despite improved general health.
In summary, survival during the first months of life and other
features of the overall phenotype of dy
3K/dE3 mice are not greatly
dependent on LMa1LG4-5.
DE3LMa1 transgene reduces the dystrophic pathology of
skeletal muscles and significantly prevents dystrophic
changes in diaphragm and heart
We next examined the morphology of dy
3K/dE3 skeletal and
heart muscle. When isolating skeletal muscles from dy
3K/dE3 mice
(5-week-old and 4-month-old and older), it could be macroscop-
ically seen that muscles were only modestly wasted (see also
Fig. 5D). However, histological analyses of muscle revealed vast
Figure 3. Restoration and upregulation of integrin a7B subunit in dy
3K/dE3 muscles. (A) Cross-sections of limb muscle (Li M), diaphragm
(Dia) and heart from wild-type, dy
3K/dy
3K and dy
3K/dE3 mice were stained with antibodies against integrin a7B. Bars, 50 mm. (B) Immunoblotting of
total protein lysates from wild-type and dy
3K/dE3 skeletal muscle and quantitative measurement of integrin a7B expression. There is approximately
4.5-fold more integrin a7B in dy
3K/dE3 muscle (p=0.0231). Results are shown as means 6 SEM.
doi:10.1371/journal.pone.0011549.g003
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3K/dE3 muscles. (A) Cross-sections of limb muscle (Li M), diaphragm (Dia), heart and sciatic
nerve (SN) from wild-type, dy
3K/dy
3K and dy
3K/dE3 mice were stained with antibody IIH6 against a-dystroglycan. Bars, 50 mm. (B) Immunoblotting of
glycoprotein preparations from wild-type and dy
3K/dE3 skeletal muscle and quantitative measurement of a- and b-dystroglycan expression. Results
are shown as means 6 SEM. No significant difference in expression of a- and b-dystroglycan was noted between wild-type and dy
3K/dE3 muscle
(p=0.8200 and p=0.7527, respectively).
doi:10.1371/journal.pone.0011549.g004
Laminin receptors in MDC1A
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presence of small fibers with centrally located nuclei (Fig. 6A).
Approximately 35% and 25% of 4–6-week-old dy
3K/dE3 quadri-
ceps and triceps muscle fibers, respectively, contained centrally
located nuclei and the numbers of centrally nucleated fibers did
not differ significantly from dy
3K/dy
3K muscles (data not shown).
The number of fibers in randomly selected areas was similar in
wild-type and dy
3K/dE3 quadriceps muscle, but with a tendency of
more fibers in dy
3K/dE3 mice (probably due to the presence of
small regenerating fibers). Interestingly, a similar number of fibers
was also noted in dy
3K/dy
3K quadriceps muscle (Figure S3).
However, average fiber diameter is smaller (data not shown) and
instead muscle contains fibrotic tissue (see Figure 8A). The number
of fibers with centrally located was even higher in limb muscles of
4-month-old dy
3K/dE3 animals, indicating that pathology worsens
over time (Fig. 6A and data not shown). Nevertheless, these results
indicate that dy
3K/dE3 muscles undergo damage but that the
constant regeneration and muscle mass is maintained with age.
Moreover, the diaphragm did not undergo degeneration/regen-
eration cycles and its morphology appeared near normal in 5-
week-old and 4-month-old animals (Fig. 6A–C). Dy
3K/dy
3K
diaphragm at 4–6-weeks of age displayed about 16% of
regenerated muscle fibers with central nuclei. A significant
reduction was found in dy
3K/dE3 diaphragm, both in young and
older animals and the numbers did not differ significantly from
wild-type diaphragm (Fig. 6B). We also determined the muscle
fiber size in 4–6-week-old diaphragm muscle. The fiber size
distribution was shifted towards smaller fiber sizes in dy
3K/dy
3K
animals, compared with wild-type muscles. Notably, the shift was
largely prevented in dy
3K/dE3 muscles (Fig. 6C).
To demonstrate functional benefit conferred by the truncated
LMa1 chain indiaphragm, we subjected dy
3K/dE3 miceto downhill
treadmill exercise and sarcolemmal integrity was evaluated by
Evans blue dye (EBD) accumulation. It has previously been shown
that only occasional EBD-positive fibers are found in dy/dy muscles
[40]. In agreement with these results, we also detected a few EBD-
positive fibers in unexercised dy
3K/dy
3K muscles. We also observed a
few EBD-positive fibers in unexercised dy
3K/dE3 limb muscles, but
almost none in dy
3K/dE3 diaphragm (Fig. 7A). While it was not
possible to exercise dy
3K/dy
3K animals, dy
3K/dE3 limb muscles were
susceptible to exercise-induced sarcolemmal injury as evidenced by
increased uptake of EBD. Interestingly, downhill running induced
very little damage in dy
3K/dE3 diaphragm (Fig. 7A). Although EBD
uptake in exercised dy
3K/dE3 limb muscles varied, both between
animals and opposing limbs within the same animal, the diaphragm
was consistently unaffected. Hence, truncated LMa1 chain prevents
exercise-induced injury in diaphragm but not in limb muscles,
indicating that different muscles have different requirements for
LMa1LG4-5 domains.
The phenomenon of progressive muscle fiber damage in the
limbs was further underscored by caspase-3 staining. Apoptosis has
been shown to contribute to the severe dystrophic changes in
muscles from MDC1A patients and LMa2 chain deficient mice
[2,41,42]. In both dy
3K/dy
3K and dy
3K/dE3 muscles either single
caspase-3 positive apoptotic fibers were detected or apoptosis was
more robust (Fig. 7B). In contrast, the muscles from LMa2 chain
deficient mice overexpressing full-length LMa1 chain (dy
3KLMa1)
were free of apoptotic fibers (no caspase-3 staining was observed,
Fig. 7B). Interestingly, apoptosis did not take place in dy
3K/dE3
diaphragms, whereas apoptotic fibers were present in diaphragms
from dy
3K/dy
3K mice (Fig. 7B). This data strongly suggests that
LMa1LG4-5 protects limb muscles from apoptosis, most probably
via dystroglycan binding, whereas truncated LMa1 chain is
sufficient to prevent apoptosis in diaphragm muscle fibers.
Regardless of apoptotic cell death, muscle replacement with
connective tissue, so evident in dy
3K/dy
3K mice [25], was not very
obvious in dy
3K/dE3 muscles (Fig. 6A). This tendency was also
demonstrated by tenascin-C staining. Tenascin-C has been shown
to be upregulated and extends to the interstitium between muscle
fibers in dy/dy and dy
3K/dy
3K mice [25,43]. Some muscles from
different dy
3K/dE3 animals showed moderate upregulation of
tenascin-C (Fig. 8A, two individuals are shown, four animals were
analyzed). However, tenascin-C expression was less pronounced
than in dy
3K/dy
3K muscles. Also, some dy
3K/dE3 limb muscles did
not display tenascin-C upregulation (Fig. 8A). Moreover, dia-
phragm did not show any signs of fibrosis (Fig. 8A).
Cardiomyopathy is not a major feature of MDC1A [1].
However, 2-month-old dy
W/dy
W hearts show infiltration of
connective tissue [44]. Dy
3K/dy
3K mice probably die too early in
order to develop heart fibrosis (data not shown). Therefore, we
compared 5–6-month-old dy
3K/dE3 hearts with hearts from 8-
week-old dy/dy mice, which show massive fibrosis in the ventricle
wall (Fig. 8B). As demonstrated by hematoxylin and eosin staining,
dy
3K/dE3 hearts did not display any fibrotic lesions (Fig. 8). This
trend was further confirmed by absence of tenascin-C staining
(Fig. 8B).
In summary, LMa1LG4-5 domains are important for securing
the mechanical stability of limb muscle fibers in LMa2 chain
deficiency, most probably by binding to dystroglycan. Interesting-
ly, LMa1LG4-5 domains are not involved in improvement of
diaphragm and heart muscle morphology, indicating that other
sites of LMa1 chain (most likely integrin a7b1 binding modules)
are responsible for functional replacement of LMa2 chain in these
muscles.
Skeletal muscle regeneration is not impaired in dy
3K/dE3
mice
Since muscle regeneration seemed to be continuously main-
tained in dy
3K/dE3 limb muscles (Fig. 6A), we next analyzed their
regenerative properties in more detail. We injected 2–3-month-old
control, dy
3K/dE3 mice and 3-week-old dy
3K/dy
3K tibialis anterior
with cardiotoxin to induce muscle damage and trigger muscle
Figure 5. Overall phenotype of dy
3K/dE3 mice. (A) 5-week-old dy
3K/dE3 mice often have normal size, remain alert and lively with good muscle
tone. A wild-type and a dy
3K/dy
3K littermate are shown for comparison. With age the difference between the body size of normal and dy
3K/dE3 mice
becomes more evident (middle panel). However some dy
3K/dE3 animals (right panel) remain undistinguishable from littermates at older age.
Nevertheless, all dy
3K/dE3 mice develop peripheral neuropathy (indicated by arrow). (B) Survival curves of dy
3K/dy
3K (n=8) and dy
3K/dE3 mice (n=44)
up to 3 months of age. Curves remain significantly different from each other (p,0.0001). Around 75% of dy
3K/dE3 mice live at least up to 3 months of
age. (C) Whole body weights of 5-week-old female control, dy
3K/dy
3K and dy
3K/dE3 mice. Body mass is partially recovered in female dy
3K/dE3 mice.
They weigh significantly more than dy
3K/dy
3K mice (p,0.0001), but significantly less than control animals p,0.0003). (D) Proportion (in percentage) of
the wet weight of quadriceps muscle to the body weight in control, dy
3K/dy
3K and dy
3K/dE3 mice. Compared to control mice, the ratio is normal in
dy
3K/dE3 (p=0.8001) but significantly reduced in dy
3K/dy
3K mice (p=0.0003). (E) Exploratory locomotion of 10-week-old control and dy
3K/dE3 mice
and 5-week-old dy
3K/dy
3K mice. Dy
3K/dE3 mice are significantly more active than dy
3K/dy
3K mice (p,0.0001) and less active than control mice
(p=0.0099). (F) Serum creatine kinase (CK) activity in control, dy
3K/dy
3K and dy
3K/dE3 mice. There is no difference in CK activity between dy
3K/dy
3K and
dy
3K/dE3 mice, but dy
3K/dE3 remain significantly different from control mice (p=0.0022) Each bar represents the mean 6 SEM.
doi:10.1371/journal.pone.0011549.g005
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reformed in all mice examined (data not shown). These fibers
expressed embryonic myosin heavy chain, indicating an ongoing
regeneration (Fig. 9B). Surprisingly, the regeneration process
clearly took place in the absence of LMa2 chain (although newly
formed muscle cells in dy
3K/dy
3K tibialis anterior were rather small)
(Fig. 9B). Tibialis anterior from dy
3K/dE3 mice also showed
normal initial regeneration, comparable to control mice. Most
importantly, after 11 days post injection, dy
3K/dE3 muscles
displayed the regeneration pattern characteristic for control mice
Figure 6. Analyses of muscle morphology and properties. (A) Hematoxylin and eosin staining of quadriceps femoris (Quad), triceps brachii (Tri)
and diaphragm (Dia) muscles from 5-week-old and 4-month-old wild-type and dy
3K/dE3 mice. Myopathic changes with groups of centrally nucleated
muscle fiberswere detectedin quadriceps, andtolargerextentintriceps ofboth 5-week-oldand4-month-old dy
3K/dE3mice.Centralnucleation wasnot
evident in diaphragm. Connective tissue infiltration was largely prevented in all muscle types. Three animals from each group were analyzed. (B)
Quantification of central nucleation in 4–6-week-old wild-type, dy
3K/dy
3K, dy
3K/dE3 and 4–6-month-old dy
3K/dE3 diaphragm. The number of fibers with
centrally located nuclei is not significantly different between wild-type and young or wild-type and old dy
3K/dE3 diaphragm muscles (p=0.2163 and
p=0.2707, respectively), whereas the number of regenerating fibers is significantly higher in dy
3K/dy
3K diaphragm compared to young and old dy
3K/dE3
mice (p=0.0255 andp=0.0026). Eachbarrepresents the mean 6 SEM (p,0.05).Atleast 3 animals were analyzed. (C) Fibersizedistributionin 4–6 week-
old wild-type, dy
3K/dy
3K, dy
3K/dE3 diaphragms. The dy
3K/dy
3K diaphragm fibers are smaller than dy
3K/dE3 diaphragm fibers. Bars, 50 mm.
doi:10.1371/journal.pone.0011549.g006
Laminin receptors in MDC1A
PLoS ONE | www.plosone.org 10 July 2010 | Volume 5 | Issue 7 | e11549Figure 7. EBD staining of unexercised and exercised muscles and caspase-3 immunostaining. (A) Three- to 5-week-old dy
3K/dy
3K mice
(not exercised) display a few EBD-positive fibers. Also, unexercised dy
3K/dE3 limb muscles display few fibers positive for EBD, whereas hardly any are
detected in dy
3K/dE3 diaphragm. Dy
3K/dy
3K mice were not in the condition to be exercised on the treadmill, but 7–13-week-old dy
3K/dE3 mice were
analyzed for EBD uptake upon exercise. Increased uptake of EBD is seen in exercised dy
3K/dE3 limb muscles, but truncated LMa1 chain prevents
exercise-induced injury in diaphragm. Bar, 200 mm. (B) Robust expression of caspase-3 (green) in the fibers from dy
3K/dy
3K and dy
3K/dE3 limb muscles
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Injected dy
3K/dE3 tibialis anterior muscles were tightly packed
with big fibers. Also, the expression of embryonic myosin heavy
chain was not detected after 11 days (Fig. 9B). This data confirms
that regeneration in the presence of truncated LMa1 chain is
characterized with high capacity and maintenance. The regener-
ation in dy
3K/dy
3K mice was delayed and not as well-organized as
in control and dy
3K/dE3 animals, since the muscle fibers in LMa2
chain deficient mice appeared to be less packed and surrounded by
connective tissue (Fig. 9A). Also, single fibers still expressed
embryonic myosin heavy chain.
In summary, these data provide more insight into mechanism of
muscle regeneration in LMa2 chain deficiency and indicate that
LMa1 chain deprived of LG4-5 domains ensures proper
regeneration. Therefore, binding to dystroglycan is not essential
to ensure sufficient muscle regeneration and its maintenance.
LMa1LG4-5 is essential for myelination in peripheral
nervous system in LMa2 chain deficiency
MDC1A patients as well as dy
3K/dy
3K mice display dysmyelina-
tion neuropathy that leads to reduced conduction velocity of
nerve impulses [45–47]. Unmyelinated axon bundles are
prominent especially in spinal roots of LMa2 chain deficient
mice. We have demonstrated before that overexpression of full-
length LMa1c h a i ni ndy
3K/dy
3K peripheral nervous system
largely corrects myelination defects [27]. Dy
3K/dE3 mice display
hindleg paralysis and motor dysfunction. Morphology analyses of
spinal roots and sciatic nerves confirmed that overexpression of
truncated LMa1 chain did not correct the phenotype of the
proximal part of peripheral nervous system. In spite of the
presence of truncated LMa1 chain in both dorsal and ventral
roots, large areas with unmyelinated axons (indicating incomplete
axonal sorting) were evident in dy
3K/dE3 mice (Fig. 10). Similar
bundles of naked, unmyelinated axons have also been described
in dorsal and ventral roots of dy
3K/dy
3K mice [27]. Importantly,
this process was fully prevented upon overexpression of full-
length LMa1c h a i ni nL M a2 chain deficient peripheral nervous
system [27], suggesting a role for LG4-5 domains in myelination
processes.
Although myelination took place in the distal part of dy
3K/dE3
peripheral nervous system, sciatic nerve morphology was only
partially rescued compared to dy
3K/dy
3K mice. Bundles of unsorted
unmyelinated axons have been reported in dy
3K/dy
3K sciatic nerve
[27] (see Fig. 10). Smaller, yet clearly visible patches of unsorted
axons were also detected in dy
3K/dE3 sciatic nerves (Fig. 10 and
11). While occasional unmyelinated axons are present in normal
animals (Fig. 11, top panel) and they are known to be part of a
healthy nerve, the bundles present in dy
3K/dE3 nerves were clearly
bigger (Fig. 11, top panel) and more frequent (data not shown),
than in control mice. Tomacula (thickened myelin sheaths) was
observed in dy/dy mice [48] and we also detected these
hypermyelinated axons in dy
3K/dy
3K animals (Fig. 10). Fewer
tomacula were seen in dy
3K/dE3 mice (Fig. 10). Electron
microscopy analyses of 2–4-month-old dy
3K/dE3 sciatic nerves
revealed a whole spectrum of pathologies. Apart from axons with
normal appearance (Fig. 11, top panel, yellow star), many axons
with myelin distortion and/or abnormal ovoid shape were
detected, especially in the animals affected more severely with
paralysis (Fig. 11, top panel, 3
rd overview photo; middle panel and
bottom panel). The post-myelination pathologies leading to axonal
degeneration (Fig. 11A–E) included: myelin degradation, axon
demyelination (B,C), myelin intrusions (A), excessive myelin
outfoldings (A,D) and redundant loops (H). Degenerated axons
often resembled Wallerian degeneration (Fig. 11E) [49]. Many
Schwann cells detached from degenerating axons (Fig. 11E, arrow)
and showed anomalous, most probably pre-apoptotic phenotype.
Further abnormalities included presence of intra-axonal vacuoles
(Fig. 11F), myelin infoldings (Fig. 11G), different forms of
hypermyelination (Fig. 11I and J) and occasional onion bulbs
(several concentric layers of Schwann cell cytoplasm around an
axon, leading to demyelination) (Fig. 11K). Schwann cells
myelinating more than one axon (satellite axons) were found
(Fig. 11F and G). This may point towards defective behavior of
Schwann cells and as a consequence a defective myelination
process. Many of the described abnormalities have not been
associated with LMa2 chain deficiency before. However, redun-
dant loop formation is characteristic for dy/dy mice [48], and we
also found many axons with redundant loops (Fig. 11H, and top
panel overview). Redundant loop formation by Schwann cells and
collapsing myelin that form ovoid, flat axons could contribute to
axonal necrosis [50]. In conclusion, it is possible that upon LMa2
chain deficiency and in the absence of full-length LMa1 chain,
Schwann cells acquire pathological properties and perform
abnormal myelination. Furthermore, with age these Schwann
cells could affect correctly assembled myelin layers, subsequently
leading to axonal neuropathy.
These data show that the presence of truncated LMa1 chain did
not prevent the possible age-related progression of pathological
processes in dy
3K/dy
3K distal peripheral nervous system. Therefore,
LMa1LG4-5 has a crucial role not only for myelination of the
spinal roots, but also for correct myelination, maintenance of
myelin, proper axon-Schwann cell interaction and peripheral
nerve homeostasis in the distal peripheral nervous system. Various
myelin and Schwann cell abnormalities have been shown to
contribute to demyelination in different neuropathies [51].
Likewise, the myelin defects described above could influence the
severity of observed neuropathy.
Basement membranes are not fully restored in the
presence of truncated LM a1 chain
LMa2 chain deficiency results in disrupted basement mem-
branes around muscle and Schwann cells [2,25,27,30,46,52,53].
Overexpression of full-length LMa1 chain largely restores
basement membranes in the neuromuscular system of dy
3K/dy
3K
mice [25,27]. In dy
3K/dE3 mice, basement membrane assembly
was only partially re-established. Both in sciatic nerves and
especially in skeletal muscle, basement membranes had a patchy
appearance (Fig. 12, A and D). In diaphragm muscle and heart,
despite significant morphological improvement, basement mem-
branes were also locally discontinuous (although to a lesser extent
than in limb muscle), suggesting that the improvement of the
phenotype is not entirely related to intact basement membranes in
these organs. Nevertheless, basement membranes in dy
3K/dy
3K
diaphragm and heart were more disrupted than in dy
3K/dE3
animals (Fig. 12, B and C).
indicated ongoing apoptosis in a large group of fibers (top Li M panel), or in single fibers (lower Li M panel). Overexpression of full-length LMa1 chain
prevented the cell death in LMa2 chain deficient limb muscles. In contrast to limb muscles, only dy
3K/dy
3K diaphragm (Dia) contained apoptotic fibers,
whereas the overexpression of both dE3LMa1 and full-length LMa1 chain prevented apoptosis in LMa2 chain deficient diaphragms. DAPI (blue) and
an antibody against collagen IV (red) were used to co-visualize apoptotic fibers. Four animals from each group were analyzed. Bars, 50 mm.
doi:10.1371/journal.pone.0011549.g007
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3K/dy
3K (4-week-old) and dy
3K/dE3 (4-
month-old) muscles (gastrocnemius, triceps, diaphragm) were stained with an antibody against tenascin-C. Occasionally tenascin-C is present in
interstitial matrix of limb dy
3K/dE3 muscles, but it is absent from diaphragm. Note extensive tissue fibrosis in dy
3K/dy
3K muscles. Four dy
3K/dE3 animals
were analyzed. Bars, 50 mm. (B) Hematoxylin and eosin staining (upper panel) of hearts from wild-type (5–6-month-old), dy/dy (8-week-old) and dy
3K/
dE3 (5–6-month-old) mice. Hearts from dy/dy mice displayed localized or extensive fibrosis in the ventricular wall. Dy
3K/dE3 hearts did not exhibit any
defects and looked as wild-type controls. Tenascin-C immunolabelling confirms the presence of fibrotic lesions in dy/dy hearts and their absence in
dy
3K/dE3 hearts (lower panel). Three animals from each group were analyzed. Bars, 50 mm.
doi:10.1371/journal.pone.0011549.g008
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required for basement membrane assembly and cell surface
anchorage in the neuromuscular system.
Discussion
In this paper, we investigated the roles of LM C-terminal
globular domains (and accordingly LM receptors dystroglycan and
integrin) in muscle and nerve and analyzed the molecular
mechanisms underlying LMa1 chain mediated rescue of LMa2
chain deficiency.
LMa1LG4-5 is dispensable for improvement of
diaphragm and heart muscles, but not limb muscles in
LMa1 chain rescued mice
Overexpression of LMa1 chain lacking LG4-5 domains in dy
3K/
dy
3K mice resulted in significantly prolonged lifespan (at least tripled
compared with dy
3K/dy
3K mice). Cardiopulmonary complications are
often responsible for the early death in dystrophic patients but
cardiomyopathy is not a common feature of LMa2c h a i nd e f i c i e n c y
[1]. Considering that a severely dystrophic diaphragm will lead to
pulmonary dysfunction, it is quite likely that the improved diaphragm
in dy
3K/dE3 mice accounts for the increased survival, although we
can not completely exclude that the expression of truncated LMa1i n
other tissues (e.g. heart) is beneficial. Importantly, integrin a7B
subunit is absent from dy
3K/dy
3K sarcolemma, but reconstituted in
dy
3K/dE3 muscles. Hence, we propose that prolonged lifespan is
secured via LMa1LG1-3 binding, most probably to integrin a7b1, in
the diaphragm and possibly in the heart.
Interestingly, while LMa1LG4-5 turned out to be dispensable for
diaphragm and heart muscle, overexpression of LMa1 chain devoid
of LG4-5 did not secure the complete correction of LMa2 chain
deficient limb muscles. Although it is not surprising that LMa2
chain deficient peripheral nerve and muscle could respond
differently to dE3LMa1 overexpression, it is somewhat unexpected
that limb muscles and diaphragm would not be spared to the same
degree, indicating an important difference in their properties or
molecular signature in response to lack of a single protein domain.
Our results also point toward diverse roles of LMa1LG4-5 when
expressed in different muscle groups. For example, apoptosis has
been shown to contribute to LMa2 chain deficient pathogenesis
[54,55]. In limb skeletal muscle, LMa1LG4-5 appeared to be
critical for prevention of apoptosis of muscle fibers. However, this
was not the case in diaphragm. Integrin a7b1 has been considered
to be the major mediator of myofiber survival [29]. Now,we suggest
that also LM binding to dystroglycan prevents apoptosis in limb
Figure 9. Analyses of skeletal muscle regenerative properties subjected to cardiotoxin injection. (A) Hematoxylin and eosin staining of
tibialis anterior from control (2–3-month-old), dy
3K/dy
3K (3-week-old) and dy
3K/dE3 (2–3-month-old) 11 days post cardiotoxin injection. Regenerating
dy
3K/dE3 muscles morphologically look like regenerating control muscles, whereas regeneration in dy
3K/dy
3K mice is delayed. (B) Immunostaining
revealingthepresenceofembryonicmyosinheavychain(eMyoH)asthesignofactiveregeneration(green).CollagenIV(CollIV)antibody(red)andDAPI
nuclear marker (blue) were chosen to co-visualize regenerating fibers. Four-days post injection (upper panel) all analyzed muscles express embryonic
myosin. Fibers from dy
3K/dy
3K mice are smaller. Eleven-days post injection (lower panel) control and dy
3K/dE3 tibialis anterior do not express embryonic
myosin. Embryonic myosin is occasionally present in some dy
3K/dy
3K fibers. Dy
3K/dy
3K tibialis anterior does not show regular morphology and displays
dystrophic, disorganized pattern with small and big muscle fibers. Three animals from each group were analyzed. Bars, 50 mm.
doi:10.1371/journal.pone.0011549.g009
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LMa2 chain has been shown to protect muscle cells in culture from
apoptosis [56]. Yet, in some muscles, (e.g. diaphragm) integrin a7b1
could be the key player in apoptosis prevention.
LMa1LG4-5 is not involved in muscle regeneration in
LMa1 chain rescued mice
Skeletal muscle regeneration depends on satellite cells, which
express both dystroglycan and integrin a7b1 [10,57]. In spite of
muscle damage and cell death, dy
3K/dE3 muscles were able to
regenerate and maintain muscle mass, both in normal conditions
and when subjected to cardiotoxin injection. Also, mini-agrin
increases the regenerative capacity of LMa2 chain deficient
muscles. Since mini-agrin binds dystroglycan (rather that integrin
a7b1), it is hypothesized that mini-agrin binding to dystroglycan is
responsible for the restored regeneration [58,59] and it has been
demonstrated that dystroglycan activity in satellite cells is crucial
for the maintenance of regeneration [10]. Yet, integrin a7 chain is
also involved in skeletal muscle regeneration, as a7 integrin-null
mice subjected to cardiotoxin injections exhibit a profound delay
in muscle regeneration [57]. Hence, integrin a7 chain is most
likely responsible for efficient muscle regeneration in dy
3K/dE3
Figure 10. Analyses of myelination in peripheral nervous system. (A) Toluidine blue staining of ventral and dorsal roots and sciatic nerves
from 2–4-month-old normal and dy
3K/dE3 mice and 5-week-old dy
3K/dy
3K animals. Myelination defects are clearly visible in dy
3K/dE3 and dy
3K/dy
3K
spinal roots with distinct and wide-spread unmyelinated axons bundles. Occasional unmyelinated axon bundles are also detected in sciatic nerve of
dy
3K/dE3 and dy
3K/dy
3K mice (indicated with arrows). Arrowheads denote tomacula. (B) Truncated LMa1 chain is present in dy
3K/dE3 spinal roots as
demonstrated by immunostaining using the antibody against N-terminal (green) and LG4 domain no staining). Four animals from each group were
analyzed. Bars, 25 mm.
doi:10.1371/journal.pone.0011549.g010
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propose that the most aggravating step in MDC1A might be the
lack of efficient regeneration due to abolished LMa2-integrin a7
interaction rather than impaired LMa2-dystroglycan interaction.
LMa1LG4-5 is vital for myelination in peripheral nerve in
LMa1 chain rescued mice
None of the neuronal symptoms that occur in LMa2 chain
deficiency were ameliorated by dE3LMa1 overexpression. This
data together with our previous work [27] indicates a very
important role for LMa1LG4-5 in LMa1 chain rescued peripheral
nervous system. Interestingly, the phenotype of dy
3K/dy
3K and dy
3K/
dE3 peripheral nervous system does not resemble the phenotype of
any conditional knockout mice, where major LM receptors
(dystroglycan, integrins b1a n db4) were depleted from Schwann
cells [18–20,60]. Furthermore, genetic inactivation of the a7
integrin chain does not affect peripheral nerve morphology and
function [60]. Therefore, those receptors might just regulate the
LMa2 chain/LMa1 chain interaction together with other recep-
tors. Heparan sulfate proteoglycans syndecans presumably bind
LMa1 via the LG4 domain [61] and are enriched in Schwann cells
[62], but syndecan-null mice do not display peripheral nerve defects
[63]. Also, sulfatides have been shown to bind LMa1LG4-5 [64]
and LMa2LG4-5 [65,66] and to be expressed in peripheral nerves
[67], where they mediate basement membrane assembly and
dystroglycan andintegrin signaling [68].Strikingly,lack ofsulfatides
Figure 11. Detailed analyses of morphology and properties of 2–4-month-old dy
3K/dE3 sciatic nerves (electron microscopy). Top
panel: Unsorted axons in wild-type (WT) and dy
3K/dE3 sciatic nerves. Most of bundles of unmyelinated axons are bigger in dy
3K/dE3 mice (enlarged
panels). Apart from unsorted axons (red arrow, overview panel), many compressed, ovoid axons, often with convoluted outfoldings and redundant
loops are seen (green arrowhead). Yet, numerous normally shaped and myelinated axons are present (yellow star). Single macrophages were
detected (blue arrow). Middle panel: Myelin defects linked to axonal degeneration. (A) Overview of a pathological area with different stages of myelin
abnormalities, myelin degradation and axonal degeneration. Red arrowhead - degenerating axon. Blue arrow - degraded interaxonal myelin leading
to axon degeneration. Green arrow - axons with vesicular or lamellar myelin debris (intrusions) and dense bodies, often being signs of early stage of
degeneration. (B–E) Detailed photos of different forms of degenerating axons found in various areas of sciatic nerve. (B) Degenerating axon with
interaxonal myelin debris. (C) An almost completely demyelinated nerve fiber is filled with dilated smooth endoplasmic reticulum and degenerated
mitochondria and undergoes degeneration. (D) Granular myelin degeneration with numerous myelin breaks. Arrowhead indicates myelin
outfoldings/redundant loop formation. (E) Axonal degeneration forgoes myelin degradation as indicated by loose non-degraded myelin swirls.
Schwann cell detached from empty myelin is indicated with arrow. Bottom panels: various axonal and myelin distortions rooting from incorrect
myelination process and/or disruption of Schwann cell properties after myelination. (F) One Schwann cell (S) contains thinly myelinated axon (a) with
vacuole (v), swollen myelin debris (arrowhead) and thickened myelin sheaths of minute axons (arrow) or myelin outfoldings. (G) Satellite myelinated
axon within a bigger axon or excessive intramyelin fold. Myelin outfoldings and satellite myelination seen in F and G may result from impaired
myelination process. (H) Redundant loop formation. (I) Hypermyelination due to excessive redundant loop formation. (J) Tomacula. (K) Onion bulb.
Arrow indicates an almost demyelinated axon. Bar, 3 mm.
doi:10.1371/journal.pone.0011549.g011
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in similar myelin abnormalities in central nervous system as in
dy
3K/dE3 distal peripheral nervous system. Hence, the LM receptor
might belong to glycolipids [69–71]. Furthermore, monosialogan-
glioside GM1has been shown to bind LM-111 and promote neurite
outgrowth [72]. Therefore, the identification of a peripheral nerve
LM receptor is an exciting task.
Basement membrane assembly in LMa1 chain rescued
mice requires LMa1LG4-5
In early studies of LMa2 chain deficiency, lack of basement
membranes was considered to be deleterious to the muscle fibers
[2,52,73,74] and to represent one of the MDC1A pathogenic
mechanisms. Consequently, the approach of basement membrane
restoration has been hypothesized to be beneficial for the
Figure 12. Basement membranes in the neuromuscular system in the absence of LMa1LG4-5. Electron microscopy of (A) limb skeletal
muscle (wild-type and dy
3K/dE3); (B) diaphragm (wild-type, dy
3K/dy
3K and dy
3K/dE3); (C) heart (wild-type, dy
3K/dy
3K and dy
3K/dE3); (D) sciatic nerve (wild-
type and dy
3K/dE3). In dy
3K/dE3 limb skeletal muscle basement membranes had patchy appearance as compared to continuous basement
membranes in wild-type samples (A) (arrowheads, in all figures). Stars depict the areas with lack of basement membrane in all figures. In dy
3K/dy
3K
diaphragm basement membranes are either patchy or completely absent. Presence of truncated LMa1 chain partially restores basement membranes
in the diaphragm (B). Similarly, in LMa2 chain deficient heart basement membranes are disrupted and partially restored upon dE3LMa1 chain
overexpression (C). Basement membranes were locally patchy around dy
3K/dE3 Schwann cells (SCh), but also sometimes continuous throughout
longer distances (D). Four animals from each group were analyzed. Bars, 400 nm.
doi:10.1371/journal.pone.0011549.g012
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Yet, continuous basement membranes are not strictly required for
myelination in peripheral nervous system [46,75]. Likewise,
basement membranes are also patchy or less dense in dy
3K/dE3
mice diaphragm and heart muscle, indicating that continuous
basement membranes are not vital for the complete correction of
the dystrophic phenotype.
Our data helps to further understand the involvement of
LMa1LG4-5 and LG1-3 in basement membrane assembly and
point toward interesting basement membrane scaffolding mech-
anisms in the neuromuscular system in the absence of LMa1LG4-
5. Exogenous LMa1LG4-5 has been shown to totally abolish the
formation of basement membranes in vitro where it selectively
blocked the cell-surface accumulation of a LM network [68,76,77].
In our in vivo model, despite lack of LMa1LG4-5, basement
membranes showed only partial defects in cell surface anchoring.
It is not excluded that integrins or other receptors that bind
LMa1LG1-3, partially could compensate for lack of LMa1LG4-5
domain and dystroglycan/sulfatide binding and anchor the LM
network to the cell surface. This accumulation, however, is not as
efficient as in the presence of full-length LMa1 chain or mini-agrin
[25,27,44,53], as basement membranes appear to be continuous
only locally in dy
3K/dE3 mice. Therefore, it is possible that all
LMa1LG domains and the cooperation between different
LMa1LG1-5 receptors are important for the assembly of
continuous basement membranes in vivo. This hypothesis is further
substantiated in McKee et al., where all LG domains were shown
to support LM tethering to cell surface [78,79]. However, very
recent data by Han et al., [15] confirms that dystroglycan, but not
integrin a7b1, is involved in basement membrane anchorage and
maintenance (rather than actual assembly) in muscle. Therefore,
LMa1LG4-5 binding to dystroglycan could be important not only
for basement membrane assembly in the muscle, but also for its
maintenance.
Supporting Information
Figure S1 Expression of dE3LMa1 chain in limb skeletal muscle
(SM), peripheral nerve (SN) and heart (He) of dE3 transgenic mice
from lines No. 3 and 4. The two antibodies to detect truncated
LMa1 chain were mAb200 and 1057+, which bind LG4 and N-
terminal domains, respectively. Mosaic expression of dE3LMa1
chain was detected in transgenic neuromuscular tissues. Wild-type
(WT) mice and full-length LMa1 chain transgenic animals
(LMa1TG) were used as controls. Bars, 50 mm.
Found at: doi:10.1371/journal.pone.0011549.s001 (3.82 MB TIF)
Figure S2 Immunostaining of LMa4 and a5 chains. Cross-
sections of quadriceps femoris (Quad), triceps brachii (Tri) and
diaphragm (Dia) from 6-week-old wild-type, dy3K/dy3K and
dy3K/dE3 mice were stained with antibodies against LMa4 chain
(A) and a5 chain (B), respectively. Expression of LMa4 and a5
chains is increased at the muscle basement area in dy3K/dy3K
mice and remains increased in dy3K/dE3 muscles. Four dy3K/
dE3 animals were analyzed. Bar, 50 mm.
Found at: doi:10.1371/journal.pone.0011549.s002 (3.67 MB TIF)
Figure S3 The numbers of fibers in a randomly selected area is
not significantly different between the genotypes.
Found at: doi:10.1371/journal.pone.0011549.s003 (0.20 MB TIF)
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